Korean Bio/Healthcare Sector Sees Ample Fund Inflows In 2021

VC Investment Tops 2020 Level, IPO Value Surges

financing
Top Fund Raisers Include SK Bioscience, HK inno.N, GI Innovation • Source: Alamy

More from South Korea

More from Focus On Asia